All patients with AML and FLT3-ITD should be transplanted in first remission. Also in the era of tyrosine kinase inhibitors? – the PRO

Haematologica 2026 Open access

Read full text
Authors: Sabine Käyser, Richard F. Schlenk
DOI: 10.3324/haematol.2025.288785
Cited by: 0

Abstract

transplanted in first remission.Also in the era of tyrosine kinase inhibitors?the PRO by

Fields of Study & Subjects

Acute Myeloid Leukemia Research Hematopoietic Stem Cell Transplantation Retinoids in leukemia and cellular processes

Publication details

Journal / source
Haematologica
Volume
111
Issue
4
Pages
1149–1152
Publication date
15 January 2026
Language
EN